DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,194 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,732 | -7.9% | 761 | -10.9% | 0.04% | -7.9% |
| Q2 2023 | $204,877 | -4.0% | 854 | +0.8% | 0.04% | 0.0% |
| Q1 2023 | $213,375 | +80.8% | 847 | +61.3% | 0.04% | +22.6% |
| Q1 2021 | $118,000 | +76.1% | 525 | +38.5% | 0.03% | +40.9% |
| Q2 2020 | $67,000 | +28.8% | 379 | 0.0% | 0.02% | +4.8% |
| Q1 2020 | $52,000 | -10.3% | 379 | 0.0% | 0.02% | +10.5% |
| Q4 2019 | $58,000 | +5.5% | 379 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $55,000 | +1.9% | 379 | 0.0% | 0.02% | -5.0% |
| Q2 2019 | $54,000 | +8.0% | 379 | 0.0% | 0.02% | -4.8% |
| Q1 2019 | $50,000 | +28.2% | 379 | 0.0% | 0.02% | +5.0% |
| Q4 2018 | $39,000 | -4.9% | 379 | 0.0% | 0.02% | +5.3% |
| Q3 2018 | $41,000 | +10.8% | 379 | +0.3% | 0.02% | -9.5% |
| Q2 2018 | $37,000 | 0.0% | 378 | 0.0% | 0.02% | -4.5% |
| Q1 2018 | $37,000 | +23.3% | 378 | +16.0% | 0.02% | 0.0% |
| Q4 2017 | $30,000 | – | 326 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |